Using Rapid Clozapine Blood Levels to Improve Patient Management – 30 Years of Clozapine Experience
Recorded at the April 2023 Annual Meeting of the American Association of Psychiatric Pharmacists
Description:
Clozapine is the only evidence-based antipsychotic option for treatment-resistant schizophrenia and patients with schizophrenia and suicidality. However, using it demands regular monitoring of a patient’s clozapine blood level. The faculty will discuss how a rapid clozapine blood level can improve managing patients’ care and how to interpret values against the patient’s response and tolerability. Professor Taylor will share his 30 years of experience working with clozapine, implementing a rapid clozapine blood test and blood level guidance that he provides within the South London and Maudsley Trust.
Presenting Faculty:
David Taylor, PhD, FRPharmS, FRCPsych (Hon)
- Director of Pharmacy and Pathology
South London and Maudsley NHS Foundation Trust, London, UK - Professor of Psychopharmacology
Institute of Pharmaceutical Science, King’s College, London, UK - Editor-in-Chief
Therapeutic Advances in Psychopharmacology
Jonathan G. Leung, PharmD, BCPS, BCPP
- Pharmacist
Department of Pharmacy, Mayo Clinic, Rochester, MN
Megan Ehret, PharmD, MS, BCPP
- Professor
Department of Practice, Sciences, and Health Outcomes Research
University of Maryland School of Pharmacy - SMI Adviser, Pharmacist Consultant
Additional Resources:
For additional handouts, questions, or inquiries, please contact hello@saladax.com or enter your email below!
